Precision medicine in type 2 diabetes: integrating trial and real-world evidence can provide accurate estimates of heart failure benefit when initiating SGLT2-inhibitors (2022)

First Author: Young K. G.
Attributed to:  Developing a decision support tool to enable precision treatment of type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 65

Parent Publication: DIABETOLOGIA

Issue: SUPPL 1

ISSN: 0012-186X